Visby Medical and Watchmaker Genomics have partnered to develop at-home PCR respiratory tests designed to overcome molecular inhibitors found in unprocessed clinical samples, according to a joint announcement.
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
The CN-3000 and CN-6000 automated analyzers deliver high-speed coagulation testing in a compact footprint for mid- to high-volume labs.
HighRes and Opentrons have partnered to develop AI agent-to-agent lab automation, integrating robotic platforms and orchestration software to enable autonomous workflows using natural language input. A live demo is planned for SLAS 2026.
Ambry Genetics supported a new study evaluating 6,718 PALB2 gene variants using MAVEs, advancing risk assessment for hereditary breast and pancreatic cancer.
